CoreCap Advisors’s LeMaitre Vascular LMAT Stock Holding History

CoreCap Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-17	Closed	-$1.63K	–	3273
2026 Q2	$1.63K	Buy	+17	New	+$1.74K	﹤0.01%	2593

Other funds holding LMAT

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

CoreCap Advisors's LMAT Position: Q3 2026 in Review

CoreCap Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 17 shares — an estimated $1.63K sold.

CoreCap Advisors first reported a position in LMAT in Q2 2026 and held it in 1 quarter. The position peaked at $1.63K in Q2 2026. 7 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

CoreCap Advisors reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
CoreCap Advisors sold 17 LeMaitre Vascular shares in Q3 2026, an estimated $1.63K.
CoreCap Advisors first reported a position in LeMaitre Vascular in Q2 2026 and held it in 1 quarter.
CoreCap Advisors's LeMaitre Vascular position peaked at $1.63K in Q2 2026.
7 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.